Gold and silver prices rose on MCX Tuesday as investors turned cautious ahead of key U.S. inflation data. Weakening hopes of a U.S.-Iran peace deal lifted crude oil prices, fuelling concerns that persistent inflation could keep global interest rates higher for longer.
Dr Reddy’s Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announced
Dr Reddy’s Laboratories Q4 Results: Dr. Reddy’s Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter versus Rs 1,587 crore